Assessing the Influence of Comfortable Nursing for Therapeutic Plasma Exchange Treatment of Severe Hepatitis Patient
Science Journal of Clinical Medicine
Volume 9, Issue 1, March 2020, Pages: 22-25
Received: Mar. 8, 2020;
Accepted: Mar. 20, 2020;
Published: Apr. 1, 2020
Views 170 Downloads 55
Xiaoxi Cai, Artificial Liver Blood Purification Department, The First Affiliated Hospital of Jinan University, Guangzhou, China
Jinglan Luo, Internal Medicine Department, The First Affiliated Hospital of Jinan University, Guangzhou, China
Jieyu Rao, Artificial Liver Blood Purification Department, The First Affiliated Hospital of Jinan University, Guangzhou, China
Yanyun Chen, Artificial Liver Blood Purification Department, The First Affiliated Hospital of Jinan University, Guangzhou, China
Danmei Weng, Artificial Liver Blood Purification Department, The First Affiliated Hospital of Jinan University, Guangzhou, China
Follow on us
Objective: To assess the Influence of Comfortable nursing for therapeutic plasma exchange treatment of severe hepatitis patient. Methods: 92 patients who were diagnosed as severe hepatitis from July 2017 to July 2018 were invited to join our study. We were randomly assigned the participants to the control group (n = 46) and the intervention group (n = 46), control group receive traditional nursing services and intervention group had additional comfortable care services. our researchers collected anxiety information and depression information by questionnaires which include Self-Rating Anxiety Scale (SAS) and Self-rating depression scale (SDS). Additionally, patient satisfaction and comfort level was collected by other questionnaires. Result: In the satisfaction research, intervention group had higher score of satisfaction assessment than that of control group [45 (97.8%) vs 39 (84.8%)]. In comfort level research, the intervention group had more 0 level assessment in our research result (n = 23). In result of SAS and SDS, the intervention group had greater improvement than that of control group in the SDS and SAS as the result of intervention group lowered scores even more. Conclusion: the comfortable care improve the outcome of therapeutic plasma exchange on severe hepatitis patient. In particular, the comfortable care greatly improve anxiety status and comfort level in the treatment process of therapeutic plasma exchange.
Therapeutic Plasma Exchange, Severe Hepatitis, Comfortable Nursing
To cite this article
Assessing the Influence of Comfortable Nursing for Therapeutic Plasma Exchange Treatment of Severe Hepatitis Patient, Science Journal of Clinical Medicine.
Vol. 9, No. 1,
2020, pp. 22-25.
Copyright © 2020 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/
) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Sugio T, Kato K, Aoki T, et al. Mogamulizumab treatment prior to allogeneic hematopoietic stem cell transplantation induces severe acute graft-versus-Host disease. Biol Blood Marrow Transplant 2016; 22 (9): 1608–1614.
Fuji S, Inoue Y, Utsunomiya A, et al. Pretransplantation anti-CCR4 antibody mogamulizumab against adult T-cell leukemia/lymphoma is associated with significantly increased risks of severe and corticosteroid-refractory graft-versus-host disease, nonrelapse mortality, and overall mortality. J Clin Oncol 2016; 34 (28): 3426–3433.
Schwartz J, et al. “Guidelines on the use of therapeutic apheresis in clinical practice_evidence-based approach from the writing committee of the american society for apheresis. The seventh special issue”. J Clin Apher 2016; 31: 149–162.
Fuji S, Shindo T. Friend or foe? Mogamulizumab in allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma. Stem Cell Investig 2016; 3 (4). 70–70.
Hosoi H, Mushino T, Nishikawa A, et al. Severe graft ‑ versus ‑ host disease after allogeneic hematopoietic stem cell transplantation with residual mogamulizumab concentration. Int J Hematol 2018 (0123456789): 31–33.
Karr EG, Meyrinck M. Padmanabhan a. Therapeutic apheresis procedures. In: Mason HM, editor. Principles of apheresis technology. sixth ed. 2017. p. 53–63 Chapter 3. AABB.
Teno JM, Gozalo PL, Bynum JP, et al. Change in end-of-life care for Medicare beneficiaries: site of death, place of care, and health care transitions in 2000, 2005, and 2009. JAMA 2013; 309: 470–7.
Hall MJ, Levant S, DeFrances CJ. Trends in inpatient hospital deaths: National Hospital Discharge Survey, 2000–2010. Center for Disease Control Data Brief. Available at: 2013.
Ortman JM, Velkoff VA, Hogan H. An aging nation: the older population in the United States population estimates and projections. US Census Bureau. Annual Report. Available at: 2016.
Simon JR, Kraus C, Rosenberg M, Wang DH, Clayborne EP, Derse AR. ‘‘Futile care’’-an emergency medicine approach: ethical and legal considerations. Ann Emerg Med 2017; 70: 707–13.
White D, Leach C, Sims R, Atkinson M, Cottrell D. Validation of the Hospital Anxiety and Depression Scale for use with adolescents. Br J Psychiatry 1999; 175: 452–454.
El-Rufaie O, Absood G. Validity study of the Hospital Anxiety and Depression Scale among a group of Saudi patients. Br J Psychiatry 1987; 151: 687–688.
McPherson R., Frohlich J., Fodor G., Genest J., Canadian cardiovascular society position statement e recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease, Can. J. Cardiol. 2006; (22): 913–927.
Meng G, Yunfeng F, Yanan Z, et al. Curative effect of therapeutic plasma exchange in the treatment of patients with severe hepatitis. Chinese Journal of Blood Transfusion. 2016; 29 (01): 64-67.
Kaplan AA. therapeutic plasma exchange: a technical and operational review. J Clin Apher 2013; 2: 3–10.
Schwartz J, Winters JL, Padmanabhan A, Balogun RA, Delaney M, Linenberger ML, et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue. J Clin Apher 2013; 28: 145-284.